Implant Sciences Explodes to Another Yearly High (IMSC)

For the third consecutive day, shares of Implant Sciences Corporation (OTC:IMSC) exploded to a new 52-week high. During trading this week, the stock has managed a gain of almost 50%, moving from $1.00 on Monday to an intraday high today of $1.48. Volume has tracked the up move with shares trading at their fastest pace in the last year. The 960,000 shares exchanging hands today was just about equal to the volume posted on Tuesday.

The stock began the day by retreating a nickel from where it ended the previous day. Buyers and sellers played tug-of-war for the first few hours as the price stayed relatively flat from the opening print. With two hours left in the trading session, buyers gave an extra pull as 400,000 shares traded in the sixty-minute period and the price of the stock moved over a dime higher.  The rally appeared to be connected with news that the company is emerging as a global player in the explosive detection industry according to an article in Government Security News, which featured Implant Sciences on the cover. At the closing bell, shares of Implant Sciences printed at $1.45, or a gain of 9.9% on the day.

The company located in Wilmington, Massachusetts manufactures and sells sophisticated sensors that are capable of detecting minute traces of explosive material. Its customers include companies from aviation, cargo, defense, and government. Implant Sciences was founded in 1984. Companies offering similar explosive detection products are Smiths Detection (OTC:SMGKF) and Morpho Detection (OTC:SAFRY).

Over the last year, insiders have made four stock transactions and all were sells. No research analysts currently follow the company, and therefore no earnings estimates are available.

Last October the stock bottomed out when it traded at $0.32. The first three months of 2012 saw the stock trading in a range between $0.50 and $0.75. In April 2012,  shares managed to climb above $1 and the price has been trending higher since. The recent move in the stock seems to be tied to several stories appearing on related to product shipments.

May 30th, 2012 – Implant Sciences adds Middle East to growing list of sniffer deployments.

May 22nd, 2012 -The company sells detection equipment to Romania.

May 16th, 2012 – Implant Sciences reports third quarter and nine month financial results. A 7% decrease in revenues for the quarter and net loss of $3.9 million caused a momentary setback for the stock.

May 14th, 2012 – China buys additional Quantum Sniffers for bomb squad use.

April 10th, 2012 – The company’s trace explosive detection equipment to be deployed at the Summit of Americas being held in Cartagena, Columbia on April 14th and 15th, 2012.


For consideration of being featured on WallstreetPR, contact:

Please make sure to read and completely understand our disclaimer at FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. Any content posted on our website is for educational and informational purposes only and should NOT be construed as a securities-related offer or solicitation, or be relied upon as personalized investment advice. WallStreetPR strongly recommends you consult a licensed or registered professional before making any investment decision. Neither nor any of its owners or employees is registered as a securities broker-dealer, broker, investment advisor (IA), or IA representative with the U.S. Securities and Exchange Commission, any state securities regulatory authority, or any self-regulatory organization. WallStreetPR often gets compensated for advertisement services that are disclosed on our disclaimer located at

Published by Alan Masterson

Alan has over 25 years of trading experience in the U.S. equity markets. He began his career in finance working on a program trading desk specializing in over-the-counter stocks. His career progressed from that point to his current position as senior trader on an institutional trading desk. In the evenings, Alan teaches economics at a local community college. He has contributed articles to various publications over the last six years, including feature articles for an economics magazine and various financial blogs. You may contact Alan via his email ( or his Google+ page (